Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
RESEARCH TOOLSreports
Holding KPRX?
Track your performance easily
KPRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.00 - $8.98
Previous Close$3.23
Volume16.18K
Average Volume (3M)24.46K
Market Cap
$9.69M
Enterprise Value-$19.27M
Total Cash (Recent Filing)$29.04M
Total Debt (Recent Filing)$72.64K
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Feb 28, 2025EPS Estimate
-$0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding3,000,788
10 Day Avg. Volume19,613
30 Day Avg. Volume24,460
Standard Deviation0.27
R-Squared0.00328
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.32
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)2.60
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.20
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-3.76
Forecast
1Y Price Target
$18.50Price Target Upside440.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Kiora Pharmaceuticals News
PremiumCompany Announcements
Kiora Pharmaceuticals Gains Approval for Phase 2 Trial
PremiumCompany Announcements
Kiora Pharmaceuticals Announces Board Appointment, Regains Nasdaq Compliance
PremiumCompany Announcements
Kiora Pharmaceuticals Unveils Updated Investor PresentationRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KPRX FAQ
What was Kiora Pharmaceuticals’s price range in the past 12 months?
Kiora Pharmaceuticals lowest stock price was $3.00 and its highest was $8.98 in the past 12 months.
What is Kiora Pharmaceuticals’s market cap?
Currently, no data Available
When is Kiora Pharmaceuticals’s upcoming earnings report date?
Kiora Pharmaceuticals’s upcoming earnings report date is Feb 28, 2025 which is in 100 days.
How were Kiora Pharmaceuticals’s earnings last quarter?
Kiora Pharmaceuticals released its earnings results on Nov 08, 2024. The company reported -$0.81 earnings per share for the quarter, missing the consensus estimate of -$0.763 by -$0.047.
Is Kiora Pharmaceuticals overvalued?
According to Wall Street analysts Kiora Pharmaceuticals’s price is currently Undervalued.
Does Kiora Pharmaceuticals pay dividends?
Kiora Pharmaceuticals does not currently pay dividends.
What is Kiora Pharmaceuticals’s EPS estimate?
Kiora Pharmaceuticals’s EPS estimate is -$0.6.
How many shares outstanding does Kiora Pharmaceuticals have?
Kiora Pharmaceuticals has 3,000,788 shares outstanding.
What happened to Kiora Pharmaceuticals’s price movement after its last earnings report?
Kiora Pharmaceuticals reported an EPS of -$0.81 in its last earnings report, missing expectations of -$0.763. Following the earnings report the stock price went down -1.401%.
Which hedge fund is a major shareholder of Kiora Pharmaceuticals?
Currently, no hedge funds are holding shares in KPRX
---
Kiora Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.50 (440.94% Upside)
$18.50 (440.94% Upside)
Insider Transactions
Bought Shares
Worth $20.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.57%
12-Months-Change
Fundamentals
Return on Equity
29.11%
Trailing 12-Months
Asset Growth
142.25%
Trailing 12-Months
Company Description
Kiora Pharmaceuticals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
---
KPRX Stock 12 Month Forecast
Average Price Target
$18.50
▲(440.94% Upside)
Technical Analysis
Best Analysts Covering KPRX
1 Year
1 Year Success Rate
1/14 ratings generated profit
1 Year Average Return
-43.02%
reiterated a buy rating 10 days ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 7.14% of your transactions generating a profit, with an average return of -43.02% per trade.
---